{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:12:26Z","timestamp":1789668746765,"version":"4.0.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1245\/s10434-026-20199-x","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:47:14Z","timestamp":1783619234000},"page":"8779-8789","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigating Age-Related Differences in Survival Outcomes and Mutation Status of Patients with Intrahepatic Cholangiocarcinoma"],"prefix":"10.1245","volume":"33","author":[{"given":"Misha","family":"Armstrong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Kalvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithat","family":"G\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghassan","family":"Abou-Alfa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod P.","family":"Balachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cercek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael I.","family":"D\u2019Angelica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Peter","family":"Kingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"O\u2019Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice C.","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Jarnagin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"20199_CR1","doi-asserted-by":"publisher","first-page":"604","DOI":"10.5604\/01.3001.0012.0929","volume":"17","author":"SO Antwi","year":"2018","unstructured":"Antwi SO, Mousa OY, Patel T. Racial, ethnic, and age disparities in incidence and survival of intrahepatic cholangiocarcinoma in the United States; 1995\u20132014. Ann Hepatol. 2018;17:604\u201314. https:\/\/doi.org\/10.5604\/01.3001.0012.0929.","journal-title":"Ann Hepatol."},{"key":"20199_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14020362","author":"F Krenzien","year":"2022","unstructured":"Krenzien F, Nevermann N, Krombholz A, et al. Treatment of intrahepatic cholangiocarcinoma: a multidisciplinary approach. Cancers Basel. 2022. https:\/\/doi.org\/10.3390\/cancers14020362.","journal-title":"Cancers Basel."},{"key":"20199_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jhep.2019.09.007","volume":"72","author":"O Clements","year":"2020","unstructured":"Clements O, Eliahoo J, Kim JU, Taylor-Robinson SD, Khan SA. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis. J Hepatol. 2020;72:95\u2013103. https:\/\/doi.org\/10.1016\/j.jhep.2019.09.007.","journal-title":"J Hepatol."},{"key":"20199_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cells11233929","author":"P Chmiel","year":"2022","unstructured":"Chmiel P, G\u0119ca K, Rawicz-Pruszy\u0144ski K, Polkowski WP, Sk\u00f3rzewska M. FGFR inhibitors in cholangiocarcinoma: a novel yet primary approach: where do we stand now and where to head next in targeting this axis? Cells. 2022. https:\/\/doi.org\/10.3390\/cells11233929.","journal-title":"Cells."},{"key":"20199_CR5","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/S0140-6736(23)00727-4","volume":"401","author":"RK Kelley","year":"2023","unstructured":"Kelley RK, Ueno M, Yoo C, et al. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023;401:1853\u201365. https:\/\/doi.org\/10.1016\/S0140-6736(23)00727-4.","journal-title":"Lancet."},{"key":"20199_CR6","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/s2468-1253(24)00095-5","volume":"9","author":"DY Oh","year":"2024","unstructured":"Oh DY, He AR, Bouattour M, et al. Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study. Lancet Gastroenterol Hepatol. 2024;9:694\u2013704. https:\/\/doi.org\/10.1016\/s2468-1253(24)00095-5.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"20199_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/bjs.4015","volume":"90","author":"JT Liang","year":"2003","unstructured":"Liang JT, Huang KC, Cheng AL, Jeng YM, Wu MS, Wang SM. Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age. Br J Surg. 2003;90:205\u201314. https:\/\/doi.org\/10.1002\/bjs.4015.","journal-title":"Br J Surg."},{"key":"20199_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15061917","author":"JW Zhu","year":"2023","unstructured":"Zhu JW, Charkhchi P, Adekunte S, Akbari MR. What is known about breast cancer in young women? Cancers Basel. 2023. https:\/\/doi.org\/10.3390\/cancers15061917.","journal-title":"Cancers Basel."},{"key":"20199_CR9","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1245\/s10434-020-08969-7","volume":"28","author":"A Khan","year":"2021","unstructured":"Khan A, Ituarte PHG, Raoof M, et al. Disparate and alarming impact of gastrointestinal cancers in young adult patients. Ann Surg Oncol. 2021;28:785\u201396. https:\/\/doi.org\/10.1245\/s10434-020-08969-7.","journal-title":"Ann Surg Oncol."},{"key":"20199_CR10","doi-asserted-by":"publisher","first-page":"14094","DOI":"10.1002\/cam4.6063","volume":"12","author":"S Reddy","year":"2023","unstructured":"Reddy S, Goksu SY, Sanford NN, et al. Characteristics and clinical outcomes in young-onset cholangiocarcinoma. Cancer Med. 2023;12:14094\u2013103. https:\/\/doi.org\/10.1002\/cam4.6063.","journal-title":"Cancer Med."},{"key":"20199_CR11","doi-asserted-by":"publisher","first-page":"e2200594","DOI":"10.1200\/po.22.00594","volume":"7","author":"L Pappas","year":"2023","unstructured":"Pappas L, Baiev I, Reyes S, et al. The Cholangiocarcinoma in the Young (CITY) study: tumor biology, treatment patterns, and survival outcomes in adolescent young adults with cholangiocarcinoma. JCO Precis Oncol. 2023;7:e2200594. https:\/\/doi.org\/10.1200\/po.22.00594.","journal-title":"JCO Precis Oncol."},{"key":"20199_CR12","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.3389\/fonc.2019.01439","volume":"9","author":"H Feng","year":"2019","unstructured":"Feng H, Tong H, Yan J, He M, Chen W, Wang J. Genomic features and clinical characteristics of adolescents and young adults with cholangiocarcinoma. Front Oncol. 2019;9:1439. https:\/\/doi.org\/10.3389\/fonc.2019.01439.","journal-title":"Front Oncol."},{"key":"20199_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","volume":"17","author":"DT Cheng","year":"2015","unstructured":"Cheng DT, Mitchell TN, Zehir A, et al. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology. J Mol Diagn. 2015;17:251\u201364. https:\/\/doi.org\/10.1016\/j.jmoldx.2014.12.006.","journal-title":"J Mol Diagn."},{"key":"20199_CR14","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1093\/jnci\/djab124","volume":"113","author":"A Cercek","year":"2021","unstructured":"Cercek A, Chatila WK, Yaeger R, et al. A comprehensive comparison of early-onset and average-onset colorectal cancers. J Natl Cancer Inst. 2021;113:1683\u201392. https:\/\/doi.org\/10.1093\/jnci\/djab124.","journal-title":"J Natl Cancer Inst."},{"key":"20199_CR15","doi-asserted-by":"publisher","first-page":"e651","DOI":"10.1016\/j.clcc.2018.06.007","volume":"17","author":"L Rodriguez","year":"2018","unstructured":"Rodriguez L, Brennan K, Karim S, Nanji S, Patel SV, Booth CM. Disease characteristics, clinical management, and outcomes of young patients with colon cancer: a population-based study. Clin Colorectal Cancer. 2018;17:e651\u201361. https:\/\/doi.org\/10.1016\/j.clcc.2018.06.007.","journal-title":"Clin Colorectal Cancer."},{"key":"20199_CR16","doi-asserted-by":"publisher","first-page":"2223375","DOI":"10.1080\/15384047.2023.2223375","volume":"24","author":"J Wang","year":"2023","unstructured":"Wang J, Shi Y, Chen J, et al. Genomic profiling, prognosis, and potential interventional targets in young and old patients with cholangiocarcinoma. Cancer Biol Ther. 2023;24:2223375. https:\/\/doi.org\/10.1080\/15384047.2023.2223375.","journal-title":"Cancer Biol Ther."},{"key":"20199_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3904\/kjim.2022.146","volume":"38","author":"JH Kim","year":"2023","unstructured":"Kim JH, Cheon YK, Lee TY, Lee SH, Chung H. Effect of age on the prognosis of intrahepatic cholangiocarcinoma. Korean J Intern Med. 2023;38:39\u201347. https:\/\/doi.org\/10.3904\/kjim.2022.146.","journal-title":"Korean J Intern Med."},{"key":"20199_CR18","doi-asserted-by":"publisher","first-page":"44995","DOI":"10.18632\/oncotarget.5707","volume":"6","author":"A Horgan","year":"2015","unstructured":"Horgan A, Knox J, Aneja P, Le L, McKeever E, McNamara M. Patterns of care and treatment outcomes in older patients with biliary tract cancer. Oncotarget. 2015;6:44995\u20135004. https:\/\/doi.org\/10.18632\/oncotarget.5707.","journal-title":"Oncotarget."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20199-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20199-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20199-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:51:47Z","timestamp":1789667507000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-20199-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["20199"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20199-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"22 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The remaining authors have no conflicts of interest.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}}]}}